2,065
Views
5
CrossRef citations to date
0
Altmetric
Pharmacology & Pharmaceutics

TRPV1 is involved in the antinociceptive effects of resveratrol in paclitaxel-induced neuropathic pain

, , , &
Pages 66-74 | Received 05 Jun 2020, Accepted 02 Dec 2020, Published online: 04 Jan 2021

References

  • Anand U, Otto WR, Anand P. 2010. Sensitization of capsaicin and icilin responses in oxaliplatin treated adult rat DRG neurons. Mol Pain. 6:82. doi:10.1186/1744-8069-6-82.
  • Argyriou AA, Bruna J, Marmiroli P, Cavaletti G. 2012. Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. Crit Rev Oncol Hematol. 82:51–77.
  • Ates O, Cayli S, Altinoz E, Gurses I, Yucel N, Kocak A, Yologlu S, Turkoz Y. 2006. Effects of resveratrol and methylprednisolone on biochemical, neurobehavioral and histopathological recovery after experimental spinal cord injury. Acta Pharmacol Sin. 27:1317–1325.
  • Ba X, Wang J, Zhou S, Luo X, Peng Y, Yang S, Hao Y, Jin G. 2018. Cinobufacini protects against paclitaxel-induced peripheral neuropathic pain and suppresses TRPV1 up-regulation and spinal astrocyte activation in rats. Biomed Pharmacother. 108:76–84.
  • Baur JA, Sinclair DA. 2006. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 5:493–506.
  • Biggs JE, Yates JM, Loescher AR, Clayton NM, Boissonade FM, Robinson PP. 2007. Changes in vanilloid receptor 1 (TRPV1) expression following lingual nerve injury. Eur J Pain. 11:192–201.
  • Brewer JR, Morrison G, Dolan ME, Fleming GF. 2016. Chemotherapy-induced peripheral neuropathy: current status and progress. Gynecol Oncol. 140:176–183.
  • Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. 1997. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 389:816–824.
  • Chen Y, Yang C, Wang ZJ. 2011. Proteinase-activated receptor 2 sensitizes transient receptor potential vanilloid 1, transient receptor potential vanilloid 4, and transient receptor potential ankyrin 1 in paclitaxel-induced neuropathic pain. Neuroscience. 193:440–451.
  • Chen K, Zhang ZF, Liao MF, Yao WL, Wang J, Wang XR. 2015. Blocking PAR2 attenuates oxaliplatin-induced neuropathic pain via TRPV1 and releases of substance P and CGRP in superficial dorsal horn of spinal cord. J Neurol Sci. 352:62–67.
  • Chiba T, Oka Y, Kambe T, Koizumi N, Abe K, Kawakami K, Utsunomiya I, Taguchi K. 2016. Paclitaxel-induced peripheral neuropathy increases substance P release in rat spinal cord. Eur J Pharmacol. 770:46–51.
  • Darby LM, Meng H, Fehrenbacher JC. 2017. Paclitaxel inhibits the activity and membrane localization of PKCα and PKCβI/II to elicit a decrease in stimulated calcitonin gene-related peptide release from cultured sensory neurons. Mol Cell Neurosci. 82:105–117.
  • Descoeur J, Pereira V, Pizzoccaro A, Francois A, Bourinet E. 2011. Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors. EMBO Mol Med. 3:266–278.
  • Di Cesare Mannelli L, Zanardelli M, Failli P, Ghelardini C. 2012. Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin. J Pain. 13:276–284.
  • Edelmayer RM, Brederson JD, Jarvis MF, Bitner RS. 2014. Biochemical and pharmacological assessment of MAP-kinase signaling along pain pathways in experimental rodent models: a potential tool for the discovery of novel antinociceptive therapeutics. Biochem Pharmacol. 87:390–398.
  • Farquhar-Smith P. 2011. Chemotherapy-induced neuropathic pain. Curr Opin Support Palliat Care. 5:1–7.
  • Girbovan C, Morin L, Plamondon H. 2012. Repeated resveratrol administration confers lasting protection against neuronal damage but induces dose-related alterations of behavioral impairments after global ischemia. Behav Pharmacol. 23:1–13.
  • Hao Y, Luo XX, Ba XY, Wang JL, Zhou SY, Yang SM, Fang CJ, Jiang CY, Sun WP. 2019. Huachansu suppresses TRPV1 up-regulation and spinal astrocyte activation to prevent oxaliplatin-induced peripheral neuropathic pain in rats. Gene. 680:43–50.
  • Hara T, Chiba T, Abe K, Makabe A, Ikeno S, Kawakami K, Utsunomiya I, Hama T, Taguchi K. 2013. Effect of paclitaxel on transient receptor potential vanilloid 1 in rat dorsal root ganglion. Pain. 154:882–889.
  • Julius D. 2013. TRP channels and pain. Annu Rev Cell Dev Biol. 29(29):355–384.
  • Kim HY, Park CK, Cho IH, Jung SJ, Kim JS, Oh SB. 2008. Differential changes in TRPV1 expression after trigeminal sensory nerve injury. J Pain: Off J Am Pain Soc. 9:280–288.
  • Liu YT, Liu W, Wang XQ, Wan ZH, Liu YQ, Leng YF. 2018. Dexmedetomidine relieves acute inflammatory visceral pain in rats through the ERK pathway, toll-like receptor signaling, and TRPV1 channel. J Mol Neurosci. 66:279–290.
  • Majithia N, Loprinzi CL, Smith TJ. 2016. New practical approaches to chemotherapy-induced neuropathic pain: prevention, assessment, and treatment. Oncology-Ny. 30:1020–1029.
  • Malin S, Molliver D, Christianson JA, Schwartz ES, Cornuet P, Albers KM, Davis BM. 2011. TRPV1 and TRPA1 function and modulation are target tissue dependent. J NeurosciOff J Soc Neurosci. 31:10516–10528.
  • Mandadi S, Armati PJ, Roufogalis BD. 2011. Protein kinase C modulation of thermo-sensitive transient receptor potential channels: implications for pain signaling. J Nat Sci Biol Med. 2:13–25.
  • Nassini R, Gees M, Harrison S, De Siena G, Materazzi S, Moretto N, Failli P, Preti D, Marchetti N, Cavazzini A, et al. 2011. Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation. Pain. 152:1621–1631.
  • Obata K, Katsura H, Mizushima T, Yamanaka H, Kobayashi K, Dai Y, Fukuoka T, Tokunaga A, Tominaga M, Noguchi K. 2005. TRPA1 induced in sensory neurons contributes to cold hyperalgesia after inflammation and nerve injury. J Clin Invest. 115:2393–2401.
  • Ozdemir US, Naziroglu M, Senol N, Ghazizadeh V. 2016. Hypericum perforatum attenuates spinal cord injury-induced oxidative stress and apoptosis in the dorsal root ganglion of rats: involvement of TRPM2 and TRPV1 channels. Mol Neurobiol. 53:3540–3551.
  • Park SB, Goldstein D, Krishnan AV, Lin CS, Friedlander ML, Cassidy J, Koltzenburg M, Kiernan MC. 2013. Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA Cancer J Clin. 63:419–437.
  • Postma TJ, Vermorken JB, Liefting AJ, Pinedo HM, Heimans JJ. 1995. Paclitaxel-induced neuropathy. Ann Oncol. 6:489–494.
  • Schwartz ES, La JH, Scheff NN, Davis BM, Albers KM, Gebhart GF. 2013. TRPV1 and TRPA1 antagonists prevent the transition of acute to chronic inflammation and pain in chronic pancreatitis. J Neurosci. 33:5603–5611.
  • Shi L, Hao ZX, Zhang SB, Wei MJ, Lu B, Wang ZT, Ji LL. 2018. Baicalein and baicalin alleviate Acetaminophen-induced liver injury by activating Nrf2 antioxidative pathway: The involvement of ERK1/2 and PKC. Biochem Pharmacol. 150:9–23.
  • Shou X, Wang B, Zhou R, Wang L, Ren A, Xin S, Zhu L. 2017. Baicalin suppresses hypoxia-reoxygenation-induced arterial endothelial cell apoptosis via suppressing PKCdelta/p53 signaling. Med Sci Monit Int Med J Exp Clin Res. 23:6057–6063.
  • Simoes RR, Dos Santos Coelho I, Do Espirito Santo CC, Morel AF, Zanchet EM, Santos AR. 2016. Oral treatment with methanolic extract of the root bark of condalia buxifolia Reissek alleviates acute pain and inflammation in mice: potential interactions with PGE2, TRPV1/ASIC and PKA signaling pathways. J Ethnopharmacol. 185:319–326.
  • Singh AK, Vinayak M. 2016. Anti-nociceptive effect of resveratrol during inflammatory hyperalgesia via differential regulation of pro-inflammatory mediators. Phytother Res. 30:1164–1171.
  • Singleton RH, Yan HQ, Fellows-Mayle W, Dixon CE. 2010. Resveratrol attenuates behavioral impairments and reduces cortical and hippocampal loss in a rat controlled cortical impact model of traumatic brain injury. J Neurotrauma. 27:1091–1099.
  • Sisignano M, Baron R, Scholich K, Geisslinger G. 2014. Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain. Nat Rev Neurol. 10:694–707.
  • Sun WP, et al. 2018. Oxytocin relieves neuropathic pain through GABA release and presynaptic TRPV1 inhibition in spinal cord. Front Mol Neurosci. 11:248. doi:10.3389/fnmol.2018.00248.
  • Tominaga M. 2010. Activation and regulation of nociceptive transient receptor potential (TRP) channels, TRPV1 and TRPA1. Yakugaku Zasshi: J Pharm Soc Jpn. 130:289–294.
  • Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, Raumann BE, Basbaum AI, Julius D. 1998. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron. 21:531–543.
  • Xu M, Cheng Z, Ding Z, Wang Y, Guo Q, Huang C. 2018. Resveratrol enhances IL-4 receptor-mediated anti-inflammatory effects in spinal cord and attenuates neuropathic pain following sciatic nerve injury. Mol Pain. 14:1744806918767549.
  • Yang YJ, Hu L, Xia YP, Jiang CY, Miao C, Yang CQ, Yuan M, Wang L. 2016. Resveratrol suppresses glial activation and alleviates trigeminal neuralgia via activation of AMPK. J Neuroinflammation. 13(1):84. doi:10.1186/s12974-016-0550-6.
  • Yuan QL, Guo TM, Liu L, Sun F, Zhang YG. 2015. Traditional Chinese medicine for neck pain and low back pain: a systematic review and meta-analysis. PloS One. 10:e0117146.